Clinical Trials Directory

Trials / Unknown

UnknownNCT03150342

Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Chest pain and myocardial ischemia are prevailing features in patients with hypertrophic cardiomyopathy (HCM). Recently introduced single-photon emission computed tomography (SPECT) cameras with solid-state cadmium-zinc-telluride (CZT) detectors have been shown to decrease imaging time and improved the imaging quality of gated myocardial perfusion imaging (MPI). The investigators also correlate the MPI parameters with echocardiographic parameters. This study is to examine the spatial distribution of stress perfusion abnormalities and tissue injury in patients with HCM using a CZT SPECT camera.

Detailed description

The investigators will retrospectively evaluate myocardial perfusion patterns and cardiac function with Thallium (Tl)-201 gated dipyridamole MPI in patients with clinical diagnosis of HCM and patent coronary angiography between January 2013 and October 2016. The inclusion criteria included a spade-like configuration on left ventriculogram, or echocardiographic findings suggestive of HCM. The participants will be then divided into the following three groups: apical, concentric and septal forms. Regional perfusion would be analyzed using a 17-segment model from 0-4 degree (0=normal, to 4=absent perfusion); and summed stress score (SSS), summed rest score (SRS) and summed difference score (SDS) were calculated. Gated SPECT would be processed by quantitative gated SPECT (QGS) software (Cedars-Sinai Medical Center, Los Angeles, CA, USA) and ejection fraction phase analysis. Diastolic parameters would be also acquired by Doppler echocardiography, and correlated with MPI parameters.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmyocardial perfusion imagingdipyridamole-stressed MPI scan using thallium-201

Timeline

Start date
2017-05-08
Primary completion
2017-08-31
Completion
2018-06-30
First posted
2017-05-12
Last updated
2017-05-16

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03150342. Inclusion in this directory is not an endorsement.